RE:More dilution ?Just found this:
https://www.i3investor.com/servlets/fdnews/170862.jsp
Noble Financial Partners the Lead agent for the financing just increased their price targets just some days before they arranged the major financing at 60 cent...
at 8. March theyconfirmed buy rating with new price target at 2,25
three weeks later they closed w hughe deal with their investors for 0,60...
so there was enough time for their investors to sell to the private investors they recommend with a upgraded price target....
i nice way to fill their pockets...
Cynapsus Therapeutic Given New $2.25 Price Target at Noble Financial (CYNAF)
|
Source: ABMN | Publish date: Sat, 8 Mar 19:49 | >> Read article in News website
Equities research analysts at Noble Financial increased their price target on shares of Cynapsus Therapeutic (NASDAQ:CYNAF) from $1.75 to $2.25 in a research note issued to investors on Tuesday, ARN reports. The firm currently has a “buy” rating on the stock. Noble Financial’s price target points to a potential upside of 87.50% from the company’s current price.
Shares of Cynapsus Therapeutic (NASDAQ:CYNAF) traded up 1.69% during mid-day trading on Tuesday, hitting $1.20. 172,520 shares of the company’s stock traded hands. Cynapsus Therapeutic has a 52 week low of $0.29 and a 52 week high of $1.39. The stock has a 50-day moving average of $0.96 and a 200-day moving average of $0.58. The company’s market cap is $46.7 million.
|